Spirometer Market (2025-2032)
The Spirometer Market is expected to reach $1.80 billion by 2032 from an estimated $0.90 billion in 2025, growing at a CAGR of 9.2% from 2025 to 2032.
- Published
- Jun 2024
- Pages
- 290
- Format
- PDF + Excel
- Report ID
- MRHC - 1041241
- Base year
- 2024
- 2025 · ESTIMATED
- $900.0M
- 2032
- $1.80B
- CAGR 2025–2032
- 9.2%
2024 baseline · 2025–2032 forecast at 9.2% CAGR · hover a bar for the value
Key highlights
By Product: In 2025, the Devices Segment to Dominate the Spirometer Market
By Technology: In 2025, the Peak Flow Measurement Segment to Dominate the Spirometer Market
By Application: In 2025, the Chronic Obstructive Pulmonary Disease (COPD) Segment to Dominate the Spirometer Market
By End User: In 2025, the Hospitals & Clinics Segment to Dominate the Spirometer Market
By Geography: In 2025, North America to Dominate the Spirometer Market
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 290 |
| Format | |
| Forecast Period | 2025–2032 |
| Base Year | 2024 |
| CAGR (Value) | 9.2% |
| Market Size (Value) | USD 1.80 billion by 2032 |
| Segments Covered | By Product · Devices · Type · Incentive Spirometers · Professional Spirometers · Digital Peak Flow Meters · Smart Digital Spirometers · Other Spirometers · Portability · Table-top/Stationary Spirometers · Handheld Spirometers · Connectivity · Wireless Spirometers · USB Spirometers · Consumables & Accessories · Software · (Note: Other spirometers include windmill-type spirometers and pneumotachometers.) · By Technology · Volume Measurement · Peak Flow Measurement · By Application · Chronic Obstructive Pulmonary Disease (COPD) · Asthma · Cystic fibrosis · Pulmonary fibrosis · Other Applications · (Note: Other applications include bronchiectasis, lung cancer, emphysema, and chronic bronchitis.) · By End User · Hospitals & Clinics · Home Care Settings · Ambulatory Care Centers |
| Countries Covered | North America (U.S., Canada), Europe (Germany, France, Italy, U.K., Spain, Switzerland, Netherlands, Rest of Europe) Asia–Pacific (India, China, Japan, Australia, South Korea, Singapore, Rest of Asia–Pacific), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of Middle East & Africa) |
| Key Companies | Hill-Rom Holdings, Inc. (U.S.) (a subsidiary of Baxter International Inc. (U.S.), Schiller Americas Inc. (U.S.), Vyaire Medical, Inc. (U.S.), Koninklijke Philips N.V.(Netherlands), KoKo, LLC (U.S.), Midmark Corporation (U.S.), Geratherm Medical AG (Germany), CHEST M.I., Inc. (Japan), Fukuda Sangyo Co., Ltd. (Japan), ndd Medical Technologies (U.S.), MGC Diagnostics Corporation (U.S.), COSMED srl (Italy), and SIBEL, SAU (Spain). |
Report overview
Segments covered: product, device, type, incentive spirometer, professional spirometer, digital peak flow meter, smart digital spirometer, other spirometer, portability, table-top/stationary spirometer, handheld spirometer, connectivity, wireless spirometer, usb spirometer, consumables & accessory, software, technology, volume measurement, peak flow measurement, application, asthma, cystic fibrosis, pulmonary fibrosis, other application, end user, hospitals & clinic, home care setting, ambulatory care center. Regions: North America, Europe, Latin America, Middle East & Africa.
The growth of this market is driven by the rising incidence of respiratory diseases, technological advancements in spirometers, increasing awareness programs regarding respiratory diseases, and the growing preference for home healthcare. However, the high cost of spirometers and a shortage of skilled professionals may restrain the market’s growth. Additionally, partnerships & collaborations between market players aimed at advancing spirometers and the rising demand from emerging economies are expected to create market growth opportunities. However, the availability of alternative technologies is a significant challenge impeding the market’s growth.
Moreover, the emergence of wearable spirometer devices and the integration of telehealth and remote monitoring with spirometry are prominent trends in the spirometer market.
Report infographic
Market dynamics
5 factors across 3 forcesRising Incidence of Respiratory Diseases
The prevalence of respiratory diseases is rising globally. Respiratory diseases are mainly caused due to smoke, infections, air pollution, dust, and chemicals. Some of the most common respiratory diseases are Chronic Obstructive Pulmonary Disease (COPD), asthma, lung cancer, pulmonary fibrosis, pneumonia, bronchitis, cystic fibrosis, and emphysema.
- According to the data published by the World Health Organization (WHO) in 2024, globally, 3.23 million deaths occurred due to COPD in 2019. Further, according to the America Lung Association (ALA), in 2022, 11.7 million people were diagnosed with COPD, chronic bronchitis.
- According to the Australian Bureau of Statistics, in 2022, 2.8 million people had asthma in Australia.
- In 2022, 20.2 million adults and 4.6 million children in the U.S had asthma. (Source: American College of Allergy, Asthma & Immunology). Furthermore, according to the Asthma and Allergy Foundation of America, in 2024, more than 27 million people in the U.S. had asthma.
Thus, the increasing prevalence of respiratory diseases drives the demand for spirometers.
Increasing Awareness Programs Regarding Respiratory Diseases
Numerous organizations have initiated respiratory disease awareness campaigns aimed at educating both patients and the general public about the importance of early detection, prevention, and management of respiratory conditions. For instance,
- In November 2024, the America Lung Association launched the ‘COPD for Life’ program to improve the lives of people living with long-term COPD.
- In September 2024, Alkem Laboratories Ltd (India) launched a campaign to increase awareness about the importance of early diagnosis and treatment of respiratory diseases.
- In May 2024, Cipla Ltd. (India) launched the ‘Tuffies’ campaign to increase pediatric respiratory care awareness and enhance treatment, especially for children with asthma.
- In November 2022, the America Lung Association launched World COPD Day to increase awareness about COPD, particularly the essential need to enhance screening, early diagnosis, and quality of life for those living with COPD.
- In May 2024, the Global Initiative for Asthma (GINA) organized the World Asthma Day (WAD) to increase awareness of asthma.
Thus, the increasing prevalence of respiratory disease awareness programs is expected to drive the growth of the spirometer market.
Table of contents
12 chapters · 120 sections · 290 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Product | Devices | — |
| By Technology | Peak Flow Measurement | — |
| By Application | Chronic Obstructive Pulmonary Disease (COPD) | — |
| By End User | Hospitals & Clinics | Home care settings |
By Product
- The Devices Segment to Dominate the Spirometer Market
- The devices segment is expected to account for the largest share of 65.2% of the spirometer market.
- This segment’s large market share can be attributed to the increasing approvals of spirometer devices, technological advancements in these devices, and their widespread adoption for monitoring disease progression.
- Additionally, the increasing global prevalence of smoking is expected to create opportunities for market growth.
- According to data released by the World Health Organization (WHO) in July 2024, 8 million individuals succumbed to smoking-related illnesses in 2022, with an additional 1.3 million non-smokers affected by passive smoking.
- In response, companies operating in this market are launching new spirometers.
- For instance, in November 2021, Cipla Ltd. (India) launched Spirofy, a portable, wireless spirometer based on pneumotach technology designed to diagnose Chronic Obstructive Pulmonary Disorder (COPD) and asthma.
By Technology
- The peak flow measurement segment is expected to account for the larger share of the spirometer market.
- This segment’s large market share can be attributed to the ease of use, portability, and cost-effectiveness of peak flow measurement spirometers.
- These devices are simpler to operate and require minimal setup compared to volume-based devices.
- Manufacturers are also developing spirometers with digital interfaces, allowing for real-time results, which further contribute to the segment’s growth.
By Application
- The Chronic Obstructive Pulmonary Disease (COPD) segment is expected to account for the largest share of the spirometer market.
- This segment’s large market share can be attributed to the high burden of Chronic Obstructive Pulmonary Disease (COPD).
- For instance, according to the National Institutes of Health (NIH), in 2022, 300 million people worldwide were diagnosed with COPD.
By End User
- The hospitals & clinics segment is expected to account for the largest share of 53.7% of the spirometer market.
- This segment’s large market share can be attributed to the high volume of patient visits for the treatment of COPD, asthma, and related emergency visits in hospitals & clinics due to the availability of healthcare professionals & advanced equipment in these healthcare settings.
- However, the home care settings segment is projected to register the highest CAGR of 9.5% during the forecast period of 2025-2032.
- This segment’s growth is driven by the increasing demand for spirometers in home care settings, the availability of spirometers specifically designed for home use, and the rising trend of telehealth and remote monitoring.
Geographic analysis
North America
Largest shareIn 2025, North America is expected to account for the largest share of 41.6% of the spirometer market, followed by Europe and Asia-Pacific. North America’s significant market share can be attributed to the increasing incidence of respiratory diseases leading to higher hospital admissions, the well-established healthcare sector, and the presence of prominent spirometer companies, such as Hill-Rom Holdings, Inc. (U.S.) and Midmark Corporation (U.S.), in this region. By Geography: In 2025, North America to Dominate the Spirometer Market
Asia-Pacific
Fastest growthHowever, the market in Asia-Pacific is projected to register the highest growth rate of 10.2% during the forecast period. The growth of this regional market can be attributed to the increasing awareness regarding the use of spirometers and the expansion of healthcare infrastructure. Additionally, the increase in respiratory disease awareness programs in countries such as China and India contributes to the market’s growth. For instance, in October 2024, Vallabhbhai Patel Chest Institute (India) launched a COPD awareness program aimed at raising awareness of COPD and supporting ongoing research in this field.
Competitive landscape
- January 2025
NuvoAir Inc. (U.S.) received the U.S. Food and Drug Administration (FDA) 510(k) clearance for NuvoAir, air next wireless spirometer. This spirometer enables people to perform detailed lung function tests in the comfort of their own homes, offering data for ongoing monitoring of diseases like asthma, chronic obstructive pulmonary disease (COPD), and amyotrophic lateral sclerosis (ALS).
- September 2024
Roundworks Technologies Private Limited (India) received the US Food and Drug Administration (FDA) for its alveoair, a portable digital spirometer. This spirometer provides real-time information to doctors and facilitates timely interventions in respiratory care.
- March 2021
Vyaire Medical, Inc. (U.S.) launched AioCare, a mobile respiratory spirometry system, to improve respiratory care.
- Baxter International Inc.
- Schiller Americas Inc.
- Vyaire Medical, Inc.
- Koninklijke Philips N.V.
- KoKo, LLC
- Midmark Corporation
- Geratherm Medical AG
- I., Inc.
- Fukuda Sangyo Co., Ltd.
- MGC Diagnostics Corporation
Frequently asked questions
The Spirometer Market involves the global industry related to devices that measure lung function and assess respiratory conditions like COPD and asthma. These devices help diagnose, monitor, and manage various respiratory diseases.
Cite this report
Meticulous Research. (2024). Spirometer Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 1041241). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/spirometer-market-5924